AVMA news
Claims about meat, poultry products come under greater USDA scrutiny
The U.S. Department of Agriculture is stepping up efforts to ensure the veracity of claims about food animal products marketed as "free range" and…
AVMA news
FDA: Congress, not rule-making, likely route for CBD availability
With the cannabidiol products market continuing to grow and after reviewing published scientific literature and information submitted to a public…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
Medicated feed against swine parasites, dysentery withdrawn
The combination medicated feed containing Safe-Guard (fenbendazole) and Lincomix (lincomycin) for use in pigs has been voluntary withdrawn by its…
AVMA news
AVMA offers resources for Pet Dental Health Month 2023
The AVMA has developed a variety of resources for National Pet Dental Health Month in February that also are available year-round to promote dental…
AVMA news
FDA warns manufacturers, distributors of unapproved antimicrobials for animals
The U.S. Food and Drug Administration (FDA) on December 14 announced it has issued nine warning letters to manufacturers and distributors of…
AVMA news
Zoetis receives $15.3M grant to improve livestock health in Africa
Zoetis announced in March that the company received a $15.3 million grant from the Bill & Melinda Gates Foundation to further develop and integrate…
AVMA news
Share your love story to help solve profession’s retention problem
Veterinary Visionaries, a collaboration of veterinary organizations, is holding a storytelling event from Feb. 14 to March 7 to answer this question:…
AVMA news
Updates from the AVMA feature resource to combat cyberbullying
AVMA leaders shared the latest Association updates during the plenary session of the 2023 AVMA Veterinary Leadership Conference. The announcements…
blog
New videos explain and demystify pet dental health
How are you celebrating National Pet Dental Health Month? AVMA's toolkit is packed with practical resources that help you spread the word about the…
blog
Key legislation approved to support animal drug development
The federal government has approved continued collection of user fees that support veterinary drug development—legislation that AVMA’s then-president…
AVMA applauds passage of legislation to enhance the review process of new and generic animal drugs
In the latest government spending bill, Congress included and passed legislation that reauthorizes the Animal Drug User Fee Act (ADUFA) and the Animal…
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
AVMA news
AVMA testifies in support of improving new animal drug review efficiency
AVMA President Lori Teller appeared before a House subcommittee to urge reauthorization of legislation supporting approval of new and generic animal…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
AVMA news
Drugs treating epilepsy, feline diabetes receive FDA approval
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat idiopathic epilepsy in dogs and…
AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
AVMA news
House Committee advances AVMA-backed xylazine language
The Administration announced its national coordinated response on July 11 to fight the deadly combination of illicit xylazine mixed with fentanyl.
AVMA news
EPA confirms registration, safety of Seresto collar
The U.S. Environmental Protection Agency (EPA) confirmed the registration and affirmed the safety profile of the Seresto flea and tick collar after a…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
From note taking to scheduling, technology can help veterinary practices in many ways
Technological developments can help many areas of practice management. It’s just a matter of taking the time and effort to make it happen, according…